General Hospital of Jinan Military Area Command

Jinan, China

General Hospital of Jinan Military Area Command

Jinan, China
SEARCH FILTERS
Time filter
Source Type

Tao T.,Shanghai University | Zhao X.,General Hospital of Jinan Military Area Command | Lou J.,Shanghai University | Bo L.,Shanghai University | And 3 more authors.
Critical Care | Year: 2012

Introduction: The objective of this study was to identify and characterize the most highly cited clinical research articles published on sepsis.Methods: A comprehensive list of citation classics in sepsis was generated by searching the database of Web of Science-Expanded (1970 to present) using keywords 'sepsis' or 'septic shock'. The top 50 cited clinical research papers were retrieved by reading the abstract or full text if needed. Each eligible article was reviewed for basic information, including country of origin, article type, journals, authors, and funding sources.Results: A total of 2,151 articles were cited more than 100 times; the 50 top-cited clinical articles were published between 1974 and 2008. The number of citations ranged from 372 to 2,932, with a mean of 678 citations per article. These citation classics came from nine countries, of which 26 articles came from the United States. Rush University and the University of Pittsburgh lead the list of classics with six papers each. The 50 top-cited articles were published in 17 journals, with the New England Journal of Medicine and Journal of the American Medical Association topping the list. The top 50 articles consisted of 21 clinical trials and 29 observational studies.Conclusions: Our bibliometric analysis provides a historical perspective on the progress of clinical research on sepsis. Articles originating from the United States and published in high-impact journals are most likely to be cited in the field of sepsis research. © 2012 Tao et al.; licensee BioMed Central Ltd.


Fang W.,Changzheng Hospital | Fang W.,Fuzhou General Hospital | Cui H.,General Hospital of Jinan Military Area Command | Yu D.,Kunming General Hospital of Chengdu Military Command | And 3 more authors.
Medical Oncology | Year: 2014

Upregulation of acetyl-CoA carboxylase (ACC), as a rate-limiting enzyme of fatty acid synthesis,has been recognized in multiple human cancers, implicating a critical role in cancer development and progression; yet, its role in gastric cancer still remains unclear. In the present study, we detected ACC and phosphorylated form of ACC (pACC) expression in gastric cancers and explored its clinical significance. Tissue microarray blocks containing primary gastric cancer and adjacent normal mucosa specimens obtained from 1,072 Chinese patients were used for the detection of ACC and pACC expression by immunohistochemistry. Gastric cancer cell lines were treated by metformin, and pACC was measured by Western blotting. ACC overexpression was observed in all the tumor specimens. High expression of pACC was found in 630 (58.8 %) of the 1,072 primary tumors and in 237 (66.6 %) of the 356 primary tumors without lymph node metastasis. Absent/low expression of pACC significantly correlated with advanced T stage (P < 0.001), tumor size (P = 0.010), lymph node metastasis (P < 0.001), advanced disease stage (P < 0.001), and poor histological differentiation (P = 0.014) in 1,072 primary tumors, and with advanced T stage (P = 0.015), tumor size (P = 0.017), and poor histological differentiation (P = 0.001) in 356 tumors without lymph node metastasis. Kaplan-Meier analysis showed that high expression of pACC is strongly related to better survival rates in all gastric cancer patients (P = 0.006). Cox regression analysis revealed that pACC is an independent prognostic factor only in patients without lymph node metastasis (P = 0.016). Metformin treatment leaded to increased expression of pACC, which, in turn, resulted in the reduction of cell proliferation and colony formation of gastric cancer cells (P < 0.05). Increased activation of ACC is frequent in human gastric cancer, and downregulation of pACC is an important prognostic factor, suggesting that ACC/pACC might be a potential target for cancer intervention. © 2014 Springer Science+Business Media.


Yue J.,General Hospital of Jinan Military Area Command | Liu Z.,Center Hospital of Feicheng Mining | Cai X.,Center Hospital of TengzhouShandong | Ding X.,Shanghai JiaoTong University | And 3 more authors.
Talanta | Year: 2016

Surface-Enhanced Raman scattering (SERS) has been widely used for imaging and sensing. However, limited reports are currently available on SERS-based cancer cell targeting strategy due to the challenge of synthesizing highly sensitive, reproducible and biocompatible SERS probe. Herein, we developed novel SERS probes, based on BSA (Bull Serum Albumin) coated gold-silver core-shell nanorods modified with Raman reporter 5,5-dithiobis 2-nitrobenzoic acid (DTNB) (Au@AgNRs@BSA@Anti-MICA), for in vitro cancer cell detection. Our results demonstrate that the SERS probe is very robust for cancer cell ultrasensitive detection with good biocompatibility and strong SERS signal. © 2016 Elsevier B.V. All rights reserved.


PubMed | Center Hospital of Feicheng Mining, General Hospital of Jinan Military Area Command, Shanghai JiaoTong University, Center Hospital of Tengzhou and PLA Fourth Military Medical University
Type: | Journal: Talanta | Year: 2016

Surface-Enhanced Raman scattering (SERS) has been widely used for imaging and sensing. However, limited reports are currently available on SERS-based cancer cell targeting strategy due to the challenge of synthesizing highly sensitive, reproducible and biocompatible SERS probe. Herein, we developed novel SERS probes, based on BSA (Bull Serum Albumin) coated gold-silver core-shell nanorods modified with Raman reporter 5,5-dithiobis 2-nitrobenzoic acid (DTNB) (Au@AgNRs@BSA@Anti-MICA), for in vitro cancer cell detection. Our results demonstrate that the SERS probe is very robust for cancer cell ultrasensitive detection with good biocompatibility and strong SERS signal.


Yue J.,General Hospital of Jinan Military Area Command | Jiao S.,General Hospital of Jinan Military Area Command | Xiao Y.,Shandong University of Traditional Chinese Medicine | Ren W.,The Fifteenth Hospital Of The Peoples Liberation Army | And 2 more authors.
International Urology and Nephrology | Year: 2015

Methods: In this 12-week prospective, randomized, and double-blind trial, we assessed the efficacy and side effects in UP patients undergoing dialysis. Patients were randomly assigned to receive 12 weeks of 75 mg twice-weekly pregabalin or 8 mg/day ondansetron or a placebo. Visits were scheduled at 0, 2, 4, 6, 8, and 12 weeks after treatment. The severity of pruritus was evaluated using Visual Analogue Scale and modified Duo’s VAG Scale. Quality of sleep was evaluated using the Pittsburgh sleep quality index. The effect of UP on health-related quality of life was assessed using the Chinese version of the 12-item short-form (SF-12) general health survey. Baseline laboratory data and demographic characteristics were recorded from patient charts.Results: Finally, 179 (108 males, 71 females, aged 54.7 ± 11.3 years old) out of the 188 patients completed the 12-week study. Of five patients who stopped pregabalin treatment due to side effects, two patients reported an improvement in nausea and vomiting among those receiving ondansetron. Two patients dropped out for renal transplantation. The 179 patients included 62 cases from the pregabalin group, 60 from the ondansetron group, and 57 from the placebo group. Over the 12 weeks, only pregabalin improved UP significantly. The severity of pruritus was reduced significantly in the pregabalin group compared with the ondansetron and the placebo groups. The final pruritus scores were not different between the ondansetron and the placebo groups. Pruritus absolutely disappeared in two patients following renal transplantation.Conclusions: Pregabalin is an effective alternative for treatment of uraemic pruritus. Ondansetron has negligible effect on uremic pruritus and is expensive. A larger sample size may be needed to demonstrate the effect of ondansetron in uraemic pruritus.Aim: Pruritus is common among patients with end-stage renal disease undergoing dialysis, and the pathogenesis can be explained by several mechanisms. However, there is no definite evidence supporting them, which limits the relative efficacy of any individual treatment option. In this paper, we aimed to compare pregabalin with ondansetron in treatment of uraemic pruritus (UP) in dialysis patients. © 2014, Springer Science+Business Media Dordrecht.


Shao Y.,PLA Fourth Military Medical University | Shao Y.,General Hospital of Jinan Military Area Command | Liang W.,General Hospital of Lanzhou | Kang F.,PLA Fourth Military Medical University | And 6 more authors.
Molecules | Year: 2014

Peptides containing the asparagines-glycine-arginine (NGR) motif have been identified as specific ligands binding to CD13/aminopeptidase N (APN) receptor, a tumor neovascular biomarker. In this study, we synthesized a novel NGR-containing peptide (NOTA-G3-NGR), and labeled NOTA-G 3-NGR with 68Ga (t1/2 = 67.7 min). The resulting 68Ga-NOTA-G3-NGR peptide was subject to in vitro and in vivo characterization. The microPET imaging results revealed that the 68Ga-NOTA-G3-NGR peptide exhibits rapid and specific tumor uptake, and high tumor-to-background contrast in a subcutaneous HT-1080 fibrosarcoma mouse model. We concluded that the 68Ga-NOTA-G 3-NGR peptide has potential in the diagnosis of CD13-targeted tumor angiogenesis. © 2014 by the authors.


Tan H.,The Second Peoples Hospital of Jinan | Wang W.,The Second Peoples Hospital of Jinan | Yin X.,Shandong University | Li Y.,General Hospital of Jinan Military Area Command | Yin R.,Shandong University
Experimental and Therapeutic Medicine | Year: 2014

The present study aimed to identify a new selective glucocorticoid receptor (GR) ligand for the treatment of chronic inflammation in type 2 diabetes mellitus. The IN Cell Analyzer 1000 platform was employed to screen for compounds that may promote GR nuclear translocation. A mammalian two-hybrid system and transactivation assaywere used to analyze the selected GR ligands and evaluate their activities for GR transcription and the recruitment of co-activators. A novel selective GR ligand, compound Q40, was identified that was able to promote GR nuclear translocation in a short period of time. It increased the ability of GR to recruit co-activators in a concentration-dependent manner, but had no positive effect on GR transcriptional activity. In conclusion, an increase in the expression levels of gluconeogeneic genes, induced by the transcriptional activation of GR, is the predisposing factor most commonly associated with the side-effects of glucocorticoids. The results suggest that compound Q40 is a ligand of the GR and exerts an agonistic action on the recruitment of co-activators without sugar dysmetabolism-related side-effects. Thus, compound Q40 has the potential to be used as an anti-inflammatory adjuvant therapy with minimal side-effects in patients with type 2 diabetes mellitus.


PubMed | The Second Peoples Hospital of Jinan, General Hospital of Jinan Military Area Command and Shandong University
Type: Journal Article | Journal: Experimental and therapeutic medicine | Year: 2014

The present study aimed to identify a new selective glucocorticoid receptor (GR) ligand for the treatment of chronic inflammation in type 2 diabetes mellitus. The IN Cell Analyzer 1000 platform was employed to screen for compounds that may promote GR nuclear translocation. A mammalian two-hybrid system and transactivation assay-were used to analyze the selected GR ligands and evaluate their activities for GR transcription and the recruitment of co-activators. A novel selective GR ligand, compound Q40, was identified that was able to promote GR nuclear translocation in a short period of time. It increased the ability of GR to recruit co-activators in a concentration-dependent manner, but had no positive effect on GR transcriptional activity. In conclusion, an increase in the expression levels of gluconeogeneic genes, induced by the transcriptional activation of GR, is the predisposing factor most commonly associated with the side-effects of glucocorticoids. The results suggest that compound Q40 is a ligand of the GR and exerts an agonistic action on the recruitment of co-activators without sugar dysmetabolism-related side-effects. Thus, compound Q40 has the potential to be used as an anti-inflammatory adjuvant therapy with minimal side-effects in patients with type 2 diabetes mellitus.


Gu L.,General Hospital of Jinan Military Area Command | Huang D.Y.,General Hospital of Jinan Military Area Command | Fu C.J.,General Hospital of Jinan Military Area Command | Wang Z.L.,General Hospital of Jinan Military Area Command | And 2 more authors.
Medical Hypotheses | Year: 2013

Cheilitis granulomatosa is a rare disease characterised by the recurrent labial swelling of one or both lips with the possibility of the condition to remain on a permanent basis. This kind of granulomatous, inflammatory disease may appear independently or be linked to a paralysis such as the facial and lingua plicata which then characteristic of the Melkersson-Rosenthal syndrome. Classically, a non-necrotizing granulomatous inflammation is seen at histologic examination. Many treatments have been tried. But as its high recurrence rate, the results were often disappointing. The major active component of Pingyangmycin is bleomycin A5. Currently, bleomycin has been proved to be a widely accepted treatment protocol for hemangiomas and lymphangioma. It has been proved that bleomycin could infiltrate prominently into lymphocytes and other inflammatory cells. Stromal connective tissue would proliferate markedly as the result of sclerotherapy. Oedema, lymphangiectasia and perivascular lymphocytic infiltration are always seen in cheilitis granulomatosa histologically. Therefore, we hypothesize that intralesional injection of Pingyangmycin plus corticosteroids may be a safe and effective treatment for cheilitis granulomatosa. The efficacy of this treatment modality is worthy of further investigation. © 2013 Elsevier Ltd.


Zhou Y.-J.,General Hospital of jiNan Military Area Command | Liu C.-J.,General Hospital of jiNan Military Area Command | Wang Y.-J.,General Hospital of jiNan Military Area Command
Journal of Interventional Radiology (China) | Year: 2013

Objective: To evaluate the clinical efficacy of partial splenic embolization (PSE) by using larger or smaller gelatin sponge particle as embolic material in treating hypersplenism due to cirrhosis. Methods: During the period from March 2010 to May 2011, a total of 52 patients with hypersplenism due to cirrhosis were treated with PSE at authors' hospital. Larger size (2 mm x 2 mm x 2 mm) or smaller size (560 ∼ 710 μm) of the gelatin sponge particle was used as embolic material. Based on the particle size used in PSE, the patients were divided into the larger particle group (n = 17) and the smaller particle group (n = 35). Splenic embolization extent of 30% ∼ 40% at 3 months after PSE was seen in 40 patients, including 16 patients of larger particle group and 24 patients of smaller particle group. During follow-up time, the white blood cell (WBC), platelet (PLT) and red blood cell (RBC) were estimated, and the postoperative complications associated with PSE were recorded. The results were analyzed. Results: In both groups, the postoperative 3-month WBC, PLT and RBC counts were significantly higher than preoperative ones (P < 0.05), although the differences in WBC, PLT and RBC counts were not significant between the two groups (P > 0.05). In the larger particle group the II and III degree of abdominal pain were seen in 13% (2/16) and 38% (6/16) of patients respectively, while in the smaller particle group the II and III degree of abdominal pain were seen in 42% (10/24) and 4% (1/24) of patients respectively; the difference between the two groups was of statistically significant (P = 0.05). The lasting time of abdominal pain in the larger particle group was 5 ∼ 20 days with a mean of (11.4 ± 4.8) days, while in the smaller particle group the lasting time of abdominal pain was 0 ∼ 8 days with a mean of (3.8 ± 2.2) days. The postoperative pain degree in the smaller particle group was slighter than that in the larger particle group (P < 0.05). No significant difference in the occurrence and the severity of fever and vomiting existed between the two groups (P > 0.05). Conclusion: No statistically significant difference in the improvement of WBC, PLT and RBC counts at 3 months after PSE exists between the larger particle group and the smaller particle group. Nevertheless, in the smaller particle group the postoperative abdominal pain is rather mild.

Loading General Hospital of Jinan Military Area Command collaborators
Loading General Hospital of Jinan Military Area Command collaborators